Diabetic retinopathy is a leading cause of visual impairment worldwide, and the DRCR (Diabetic Retinopathy Clinical Research) Retina Network has been instrumental in developing treatment protocols, particularly through anti-VEGF therapies. The gene discussed is VEGFA; the disease is diabetic retinopathy.